CLINICAL TRIALS PROFILE FOR NESINA
✉ Email this page to a colleague
All Clinical Trials for Nesina
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00856284 ↗ | Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes Mellitus | Completed | Takeda | Phase 3 | 2009-03-01 | The purpose of this study is to determine the safety and effectiveness of adding alogliptin, once daily (QD), compared to glipizide with metformin in diabetic patients. |
NCT01664624 ↗ | Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes | Completed | AstraZeneca | Phase 1 | 2012-07-01 | The purpose of this study is to assess the effect of roflumilast plus alogliptin on glucagon-like peptide-1 (GLP-1) and glucose levels in patients with type 2 diabetes. |
NCT01664624 ↗ | Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes | Completed | Takeda | Phase 1 | 2012-07-01 | The purpose of this study is to assess the effect of roflumilast plus alogliptin on glucagon-like peptide-1 (GLP-1) and glucose levels in patients with type 2 diabetes. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Nesina
Condition Name
Clinical Trial Locations for Nesina
Trials by Country
Clinical Trial Progress for Nesina
Clinical Trial Phase
Clinical Trial Sponsors for Nesina
Sponsor Name